USA v. Holmes et al
Case Number:
5:18-cr-00258
Court:
Nature of Suit:
Judge:
Firms
-
November 10, 2021
Theranos Exec Threatened Investor With Litigation, Jury Told
A retired money manager testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Wednesday that Holmes cut off communication when he asked for information, and his request to liquidate investments in emails titled "PLEASE RESPOND!!!" were met with litigation threats from Theranos executive and Holmes' then-romantic partner Ramesh "Sunny" Balwani.
-
November 09, 2021
Ex-Theranos Lab Chief Doubted Holmes' 'Implausible' Takes
Theranos' fourth and final lab director testified in the criminal fraud trial of former CEO Elizabeth Holmes on Tuesday that within weeks of being hired, he discovered that Theranos had "global" quality control problems and found the various explanations Holmes offered "implausible."
-
November 05, 2021
4 BigLaw Players In Elizabeth Holmes' Criminal Fraud Trial
In the two months since the start of former Theranos CEO Elizabeth Holmes' fraud trial, jurors have heard a variety of testimony highlighting the role several BigLaw firms and their attorneys played in the rise and fall of the once high-flying blood-testing startup.
-
November 04, 2021
Holmes Cited Walgreens Deal In Rushing Investors, Jury Told
A Black Diamond Venture executive testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Thursday that Holmes gave him less than a month in late 2013 to decide whether to invest $5.4 million in the blood-testing company, telling investors the compressed timeline was to accommodate a deadline in Theranos' deal with Walgreens.
-
November 03, 2021
Boies Said Theranos Tech Was Sound, Investors' Atty Testifies
A former Cravath Swaine & Moore LLP partner testified in former Theranos CEO Elizabeth Holmes' criminal fraud trial on Wednesday that he personally invested $6 million into the company after its then-attorney David Boies told him the startup's technology was "absolutely sound and performing well," and that the company's largest risk was its rollout.
-
November 02, 2021
Ex-Cravath Atty Introduced Rich Clients To Holmes, Jury Told
A former Cravath Swaine & Moore partner testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Tuesday that he introduced high-net-worth clients — including the DeVos, Cox and Walton families — to Holmes and personally invested $6 million after he analyzed the startup for his longtime client, then-Theranos board member Henry Kissinger.
-
October 26, 2021
DeVos Family Gave Theranos $100M 'On The Spot,' Jury Told
A DeVos family wealth manager testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Tuesday that the family committed "on the spot" to doubling their $50 million investment in Theranos during a visit to its headquarters, while defense counsel probed the manager during a tense cross-examination on the family's due diligence.
-
October 22, 2021
Ex-Pfizer Scientist Rips Report Holmes Sent To Walgreens
In former Theranos CEO Elizabeth Holmes' criminal fraud trial on Friday, a former Pfizer scientist testified that a report Holmes sent to Walgreens used Pfizer's name and logo without permission and falsely claimed the pharmaceutical company had independently evaluated Theranos' technology, even though Pfizer had concluded Theranos' test results were "not believable."
-
October 20, 2021
Holmes Was Coached By Marketing Firms, Jury Told
A California federal jury hearing the criminal fraud case against former Theranos CEO Elizabeth Holmes viewed emails Wednesday showing that she was coached by marketing firms about what to say to journalists and how to avoid unwelcome questions that are "needlessly controversial."
-
October 19, 2021
Holmes OK'd Testing Claims Over Atty's Concerns, Jury Told
An ex-Theranos senior project manager testified in former Theranos CEO Elizabeth Holmes' criminal fraud trial Tuesday that Holmes approved Theranos' websites and presentations shown to the military and high-profile investors that said Theranos' minilabs could run "any test available in central labs" despite in-house counsel's objections to the language.